In January, the Alabama Supreme Court ruled that drug manufacturer Pfizer can be sued by a man who alleges he was injured by a generic formulation of its heartburn medication Reglan. Pfizer allegedly failed to warn the man’s physician about the drug’s risks.<\/p>\n
The decision has caused much alarm among drugmakers, and Pfizer has requested a re-hearing. The ruling is one of only a few in which a court has ruled that a drug manufacturer may be sued for injuries allegedly caused by a generic version of its product.<\/p>\n
The pharmaceutical industry worries that the decision will encourage more such lawsuits, particularly in light of a 2011 case in which the U.S. Supreme Court ruled that generic drugmakers are not required to update safety warnings on their product labels when they become newly aware of possible side effects. This effectively protects manufacturers of generics from being sued for not advising patients of such (more…)<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":" In January, the Alabama Supreme Court ruled that drug manufacturer Pfizer can be sued by a man who alleges he was injured by a generic formulation of its heartburn medication Reglan. Pfizer allegedly failed to warn the man’s physician about…<\/span><\/p>\n